Literature DB >> 22454085

Carnosine and cancer: a perspective.

Frank Gaunitz1, Alan R Hipkiss.   

Abstract

The application of carnosine in medicine has been discussed since several years, but many claims of therapeutic effects have not been substantiated by rigorous experimental examination. In the present perspective, a possible use of carnosine as an anti-neoplastic therapeutic, especially for the treatment of malignant brain tumours such as glioblastoma is discussed. Possible mechanisms by which carnosine may perform its anti-tumourigenic effects are outlined and its expected bioavailability and possible negative and positive side effects are considered. Finally, alternative strategies are examined such as treatment with other dipeptides or β-alanine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454085     DOI: 10.1007/s00726-012-1271-5

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  21 in total

Review 1.  Possible Benefit of Dietary Carnosine towards Depressive Disorders.

Authors:  Alan R Hipkiss
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 2.  Self-Assembled Peptide Nanostructures for ECM Biomimicry.

Authors:  Davide Marin; Silvia Marchesan
Journal:  Nanomaterials (Basel)       Date:  2022-06-22       Impact factor: 5.719

3.  Screening human lung cancer with predictive models of serum magnetic resonance spectroscopy metabolomics.

Authors:  Tjada A Schult; Mara J Lauer; Yannick Berker; Marcella R Cardoso; Lindsey A Vandergrift; Piet Habbel; Johannes Nowak; Matthias Taupitz; Martin Aryee; Mari A Mino-Kenudson; David C Christiani; Leo L Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

4.  Protective effect of carnosine and N-acetylcysteine against sodium nitrite-induced oxidative stress and DNA damage in rat intestine.

Authors:  Fariheen Aisha Ansari; Aijaz Ahmed Khan; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-04       Impact factor: 4.223

5.  Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis.

Authors:  Poonam Gautam; Sudha C Nair; Manoj Kumar Gupta; Rakesh Sharma; Ravindra Varma Polisetty; Megha S Uppin; Challa Sundaram; Aneel K Puligopu; Praveen Ankathi; Aniruddh K Purohit; Giriraj R Chandak; H C Harsha; Ravi Sirdeshmukh
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer.

Authors:  Peter Arner; Frauke Henjes; Jochen M Schwenk; Spyros Darmanis; Ingrid Dahlman; Britt-Marie Iresjö; Peter Naredi; Thorhallur Agustsson; Kent Lundholm; Peter Nilsson; Mikael Rydén
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

7.  Carnosine Inhibits the Proliferation of Human Gastric Carcinoma Cells by Retarding Akt/mTOR/p70S6K Signaling.

Authors:  Zhenwei Zhang; Lei Miao; Xin Wu; Guangze Liu; Yuting Peng; Xiaoming Xin; Binghua Jiao; Xiangping Kong
Journal:  J Cancer       Date:  2014-04-24       Impact factor: 4.207

8.  Carnosine: can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential?

Authors:  Alan R Hipkiss; Stephanie P Cartwright; Clare Bromley; Stephane R Gross; Roslyn M Bill
Journal:  Chem Cent J       Date:  2013-02-25       Impact factor: 4.215

9.  β-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro.

Authors:  Roger A Vaughan; Nicholas P Gannon; Randi Garcia-Smith; Yamhilette Licon-Munoz; Miguel A Barberena; Marco Bisoffi; Kristina A Trujillo
Journal:  Mol Cancer       Date:  2014-01-24       Impact factor: 27.401

10.  Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts.

Authors:  Zuzana Ditte; Peter Ditte; Martina Labudova; Veronika Simko; Filippo Iuliano; Miriam Zatovicova; Lucia Csaderova; Silvia Pastorekova; Jaromir Pastorek
Journal:  BMC Cancer       Date:  2014-05-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.